Glaxo stops funding commercial CME; Merck funding $150M non-profit vaccine developer;

> In another sign that drugmakers want to reduce their exposure to payola allegations, GlaxoSmithKline has announced that it will stop funding commercial continuing medical education programs. FiercePharma

> Working with the UK's Wellcome Trust, Merck is funding a $150 million non-profit vaccine developer focused on inexpensive shots for developing countries. FierceVaccines

> Could Hispanics be the next big market for mobile healthcare innovation? Some experts--including former Al Gore spokesman Jonathan Spalter--say there's a big opportunity here to improve this population's health. FierceMobileHealthcare

> A group of UCLA researchers seem to have found a way to make paralyzed rates capable of walking again, using drugs, electrical stimulation and regular exercise. FierceBiotechResearch

And Finally... Hey, buddy, why didn't you just subscribe to Netflix yourself, for heaven's sake? Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.